KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
Durham, North Carolina (April 15, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and...
Accelerating timelines vital to securing slice of biosimilars market, KBI
By Dan Stanton+, 24-Aug-2016
Accelerated development gives biosimilars an upper hand in gaining market share, CMO KBI Biopharma told delegates in Korea yesterday.
Durham, North Carolina (April 15, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and...
Durham, North Carolina (April 1, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing...
KBI Biopharma, a JSR Life Sciences Company and leading global Contract Development and Manufacturing Organization (CDMO) has received six awards in...